Haematology Consultant - Myeloma Disorders | The Christie NHS Foundation Trust

Dyddiad hysbysebu:	29 Ionawr 2026
Cyflog:	Heb ei nodi
Gwybodaeth ychwanegol am y cyflog:	£109,725 - £145,478 Per Annum Pro Rata
Oriau:	Llawn Amser
Dyddiad cau:	28 Chwefror 2026
Lleoliad:	Manchester, M20 4BX
Cwmni:	The Christie NHS Foundation Trust
Math o swydd:	Parhaol
Cyfeirnod swydd:	7771988/413-MD-C2025-24839-OO

Crynodeb

We are seeking an exceptional full time Haematology Consultant (10 Programmed Activities) to join our highly specialised Myeloma and Plasma Cell Disorders Service. This is an exciting opportunity to contribute to a rapidly expanding NHS service and research programme, delivering cutting edge therapies to patients across the North West, North Wales and beyond.


As a Myeloma UK Centre of Excellence, our service offers an exciting environment for innovation within a dynamic, multidisciplinary team. The Christie’s Haematology Department is a JACIE accredited centre providing Stem Cell Transplantation, CART and other immunotherapies, with a strong track record in advanced biological treatments.


This post also offers the chance to introduce and develop emergent myeloma treatments, supporting significant planned growth in the myeloma service. There is also a supra-regional interest in Castleman’s disease, in POEMS and other overlap syndromes. The Christie’s main site is currently the sole initiating centre for bispecific therapies for a population of approximately 1.5 million people. We anticipate and are strategically planning for a substantial expansion of available treatments over the coming years.


The post will involve phase 2a and 3 clinical trials in myeloma and with potential for investigator-initiated studies and also will interface closely with our early phase research team.
An Advisory Appointment Committee (AAC) Panel has been set for 22nd April 2026.

As a key member of the Haematology Department, you will:


Provide consultant-level leadership in the development and delivery of the Myeloma service.

Act as a core member of the Myeloma MDT, collaborating with expert colleagues across haematology, oncology, pharmacy, nursing, and allied health.

Support the autologous stem cell transplant programme for Myeloma and plasma cell disorders.

Expand and deliver a robust portfolio of phase 2–4 clinical trials for myeloma and related disorders, working closely with the Early Phase Trials Unit and clinician scientists within the MCRC.

Contribute to the development of CNS- and pharmacist-led services.Deliver three clinics (including research, new/transplant and review/therapy) per week in conjunction with other members of the myeloma service.

Support The Chrisie Haematology MDT, covering a population greater than 1.5 million.

Participate in the consultant attending rota for inpatient services and the out-of-hours on‑call rota.

Provide occasional laboratory cover, including blood film reporting support.

Serve as Lead Consultant for Blood Transfusion, chairing the Hospital Transfusion Team and contributing to the Hospital Transfusion Committee.

The Christie is one of Europe’s leading cancer centres, treating over 60,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester & Cheshire, but as a national specialist around 15% patients are referred to us from other parts of the country.

We provide radiotherapy through one of the largest radiotherapy departments in the world; chemotherapy on site and through 14 other hospitals; highly specialist surgery for complex and rare cancer; and a wide range of support and diagnostic services. We are also an international leader in research, with world first breakthroughs for over 100 years.

We run one of the largest early clinical trial units in Europe with over 300 trials every year. Cancer research in Manchester, most of which is undertaken on the Christie site, has been officially ranked the best in the UK.

Please review attached Job Description and Person specification (JD&PS) for a full detail job description and Main responsibilities.

Job Plan Timetable

The timetable below is indicative and will be confirmed on commencement in post.

It is the requirement of the Trust that all new consultant colleagues must have 0.25 SPAs within their job plan to support Trust appraisal and supervision requirements. This can either be as appraiser or a supervisor for medical staff or Advanced Clinical Practitioners (ACP).



Monday

Tuesday

Wednesday

Thursday

Friday

AM

SPA/Admin

Clinical Admin

New patient Clinic

SCT reviews

Ward Round

Follow-up Clinic

PM

SRFT MDT/Admin

Potential Research Clinic

Christie MDT

Departmental meetings/CPD

Patient Admin



NB This timetable is indicative

Job Plan PA Summary
Total PAsDirect Clinical Care (DCC)
7.5

Supporting Professional Activities (SPA) (including 1.5 core SPA)

2.5

Supervision role (minimum 0.25 must be allocated)

0.25
Total Programmed Activities (PAs)


10

On call Commitments

This role does require participation in the on-call rota.


This advert closes on Thursday 19 Feb 2026

Aelod balch o'r cynllun cyflogwyr Hyderus o ran Anabledd

Gwybodaeth am Hyderus o ran Anabledd

Yn gyffredinol, bydd cyflogwr Hyderus o ran Anabledd yn cynnig cyfweliad i unrhyw ymgeisydd sy'n datgan eu bod yn anabl ac yn bodloni'r meini prawf lleiaf ar gyfer y swydd fel y diffinnir gan y cyflogwr. Mae'n bwysig nodi, mewn rhai sefyllfaoedd recriwtio fel nifer fawr o ymgeiswyr, cyfnod tymhorol ac amseroedd prysur iawn, efallai y bydd y cyflogwr am gyfyngu ar y niferoedd cyffredinol o gyfweliadau a gynigir i bobl anabl a phobl nad ydynt yn anabl. Am fwy o fanylion ewch i Hyderus o ran Anabledd.